We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Gold Standard Diagnostics

Provides comprehensive diagnostic solutions to improve lab efficiency and minimize overall costs read more Featured Products: More products

Download Mobile App





Gold Standard Diagnostics Highlights Updated AIX1000 Automated RPR Test System

By LabMedica International staff writers
Posted on 25 Jul 2022

Gold Standard Diagnostics (Davis, CA, USA) is highlighting its comprehensive diagnostic solutions at the 2022 AACC Clinical Lab Expo, including a suite of automated instruments for immunoblot, ELISA, and agglutination testing, and an extensive menu of assays for autoimmune, infectious disease, endocrinology, and more. More...



At AACC 2022, Gold Standard Diagnostics will be presenting the new version of the AIX1000 Automated RPR Test System with improved software and hardware features. The AIX1000 is an FDA cleared, CE marked, fully automated system for nontreponemal, rapid plasma reagin (RPR) testing. It has been designed to simplify the processing, analysis, result interpretation, and archiving for RPR screens and semi-quantitative titers. The AIX1000 is the world’s first fully automated system for nontreponemal RPR Syphilis testing. Users simply need to load their reagents and up to 192 samples, then walk away. The AIX automates the processing, analysis, reporting and archival of results for both RPR screens and titers.

The AIX1000 allows users to run flexible batch sizes of up to 192 samples in 90 minutes and performs RPR screens and/or titers using automated protocols. It employs a single, dual needle probe to aliquot Gold Standard Diagnostics’ RPR reagents in up to 4, 48 well microtiter plates, and an orbital shaker to perform the automated RPR test procedure. A built-in magnetic stir plate maintains carbon reagent suspension during the run.

The AIX1000 provides full sample traceability from loading to result reporting and archiving. An HD camera generates images of RPR test results that are stored digitally and are retrievable on demand. The RPR test procedure and results interpretation are fully automated, thus reducing variation associated with manual testing & interpretation. It also reduces the amount of labor overhead dedicated to RPR testing, freeing personnel to increase productivity across laboratory operations and improving the quality & consistency of results.

One of the key highlights of the updated AIX1000 Automated RPR Test System is the new universal slide-in rack system that accommodates a variety of tube sizes, making sample loading even easier and faster. Additional key updates include improved database management, thereby cutting the time to perform backup/restorations by half as well as remote data archiving capabilities, and an expandable status log.
 

Related Links:
Gold Standard Diagnostics 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.